{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:30:37Z","timestamp":1790044237950,"version":"4.0.1"},"reference-count":359,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01379","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T15:57:11Z","timestamp":1575907031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["The Pharmacology of Visual Hallucinations in Synucleinopathies"],"prefix":"10.3389","volume":"10","author":[{"given":"Mirella","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna Gabriella","family":"Rispoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Luca","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00213-011-2470-6","article-title":"Acute and post-acute behavioral and psychological effects of salvinorin A in humans","volume":"220","author":"Addy","year":"2012","journal-title":"Psychopharmacol. (Berl)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s15010-004-3121-1","article-title":"Voriconazole-induced musical hallucinations","volume":"32","author":"Agrawal","year":"2004","journal-title":"Infection"},{"key":"B3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacological effect of serotoninergic regulation of dopamine transmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacologic Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuroscience.2005.11.012","article-title":"Differential response dynamics of corticothalamic glutamatergic synapses in the lateral geniculate nucleus and thalamic reticular nucleus","volume":"137","author":"Alexander","year":"2006","journal-title":"Neuroscience"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1345\/aph.1P008","article-title":"Bennett and Tania M Vila, The role of ondansetron in the treatment of schizophrenia","volume":"44","author":"Allisoc","year":"2010","journal-title":"Ann. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/nyas.12360","article-title":"The default network and self-generated thought: component processes, dynamic control, and clinical relevance","volume":"1316","author":"Andrews-Hanna","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/15563650701241795","article-title":"Opioid receptors and legal highs:Salvia divinorumand Kratom","volume":"46","author":"Babu","year":"2008","journal-title":"Clin. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/070674376801300620","article-title":"Psycothic reactions during amytriptyline therapy","volume":"13","author":"Baldessarini","year":"1968","journal-title":"Can. Psychiatr. Assoc. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0140-6736(05)78999-6","article-title":"Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease","volume":"351","author":"Ballard","year":"1998","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jnnp.2007.116202","article-title":"Executive functions are impaired in patients with Parkinson's disease with visual hallucinations","volume":"79","author":"Barnes","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","article-title":"Visual hallucinations in Parkinson's disease: a review and phenomenological survey","volume":"70","author":"Barnes","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0028-3932(02)00182-3","article-title":"Reality monitoring and visual hallucinations in Parkinson's disease","volume":"41","author":"Barnes","year":"2003","journal-title":"Neuropsychologia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E1382","DOI":"10.1073\/pnas.1525586113","article-title":"Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning","volume":"8113","author":"Barre","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/pb.bp.113.045518","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment","volume":"39","author":"Barry","year":"2015","journal-title":"BJPsych. Bull."},{"key":"B16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0269881105057696","article-title":"Dysregulation of thalamic sensory \u201ctransmission\u201d in schizophrenia: neurochemical vulnerability to hallucinations","volume":"20","author":"Behrendt","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/mds.27557","article-title":"Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease","volume":"34","author":"Bejr-Kasem","year":"2019","journal-title":"Mov. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00401-007-0260-3","article-title":"Rostral raphe involvement in Lewy body dementia and multiple system atrophy","volume":"114","author":"Benarroch","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182886a76","article-title":"Pedunculopontine nucleus: functional organization and clinical implications","volume":"80","author":"Benarroch","year":"2013","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","article-title":"Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia","volume":"357","author":"Berridge","year":"2014","journal-title":"Cell Tissue Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0896-6273(94)90279-8","article-title":"Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel","volume":"12","author":"Bochet","year":"1994","journal-title":"Neuron"},{"key":"B23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/ALN.0000000000001275","article-title":"Resting-state Network-specific Breakdown of Functional Connectivity during Ketamine Alteration of Consciousness in Volunteers","volume":"125","author":"Bonhomme","year":"2016","journal-title":"Anesthesiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.3037705","article-title":"Identification of a family of muscarinic acetylcholine receptor genes","volume":"237","author":"Bonner","year":"1987","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"17e22","DOI":"10.1016\/j.parkreldis.2015.11.013","article-title":"Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients, Parkinsonism","volume":"23","author":"Borgemeester","year":"2016","journal-title":"Relat. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41235-017-0063-6","article-title":"Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders","volume":"2","author":"Bowman","year":"2017","journal-title":"Cogn. Res. Principles Implications"},{"key":"B27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00213-006-0639-1","article-title":"Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement","volume":"190","author":"Braida","year":"2007","journal-title":"Psychopharmacol. (Berl.)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1755-5949.2011.00247.x","article-title":"Hallucinations in neurodegenerative diseases","volume":"18","author":"Burghaus","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/mds.21077","article-title":"Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease","volume":"21","author":"Burn","year":"2006","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/014107688808100521","article-title":"Organic psychosis caused by diltiazem","volume":"81","author":"Bushe","year":"1988","journal-title":"J. R. Soc. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","article-title":"Dark Classics in Chemical Neuroscience: N,N-Dimethyltryptamine (DMT)","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hup.640","article-title":"Factors associated with complex visual hallucinations during antidepressant treatment","volume":"19","author":"Cancelli","year":"2004","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/(SICI)1096-9861(19990802)410:3<431::AID-CNE6>3.3.CO;2-I","article-title":"Location of muscarinic type 2 receptors within the synaptic circuitry of the cat visual thalamus","volume":"410","author":"Carden","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1177\/0269881110367445","article-title":"The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability","volume":"25","author":"Carhart-Harris","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris","year":"2013","journal-title":"Schizophr. Bull."},{"key":"B38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/biom9080388","article-title":"A stage-based approach to therapy in parkinson's disease","volume":"9","author":"Carrarini","year":"2019","journal-title":"Biomolecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.neubiorev.2015.05.011","article-title":"The muscarinic system, cognition and schizophrenia","volume":"55","author":"Carruthers","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/S0140-6736(02)11998-2","article-title":"But who is that on the other side of you?Extracampine hallucinations revisited","volume":"360","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0253-7613.108316","article-title":"Ofloxacin-induced hallucinations","volume":"45","author":"Chauhan","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1124\/jpet.103.059394","article-title":"An active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations","volume":"308","author":"Chavkin","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1046\/j.1440-1681.1999.03151.x","article-title":"The 'ABC' of GABA receptors: a brief review, Clin","volume":"26","author":"Chebib","year":"1999","journal-title":"Exp. Pharmacol. Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuroscience.2015.05.035","article-title":"\u03b1-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca(2+) influx upon NMDA stimulation","volume":"300","author":"Chen","year":"2015","journal-title":"Neuroscience"},{"key":"B48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0022-510X(91)90193-B","article-title":"Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases","volume":"106","author":"Cheng","year":"1991","journal-title":"J. Neurological Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0140525X12000477","article-title":"Whatever next? Predictive brains, situated agents, and the future of cognitive science","volume":"36","author":"Clark","year":"2013","journal-title":"Behav. Brain Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.ajem.2014.08.051","article-title":"Neuropsychiatric side effects due to a transdermal fentanyl patch: hallucinations","volume":"33","author":"Colak","year":"2015","journal-title":"Am. J. Emergency Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1017\/S0140525X05000130","article-title":"Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations","volume":"28","author":"Collerton","year":"2005","journal-title":"Behav. Brain Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1038\/cddis.2011.57","article-title":"New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc","author":"Corona","year":"2011","journal-title":"Cell Death Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1526-4637.2004.04043.x","article-title":"Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome","author":"Correll","year":"2004","journal-title":"Pain Med. Malden Mass."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J. Neurochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0091-3057(01)00644-X","article-title":"Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies","volume":"70","author":"Court","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"B58","first-page":"368","article-title":"Primavanserin (Nuplazid), in a treatment for hallucinations and delusions associated with Parkinson's disease","volume":"42","author":"Cruz","year":"2017","journal-title":"P. T"},{"key":"B59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000048636","article-title":"Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies","volume":"13","author":"Cummings","year":"2002","journal-title":"Dement Geriatr. Cognit. Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"The Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/3-540-06498-2_3","article-title":"Amino acid transmitters in the mammalian central nervous system, Ergeb","volume":"69","author":"Curtis","year":"1974","journal-title":"Physiology"},{"key":"B62","first-page":"36","article-title":"Vortioxetine (brintellix): a new serotonergic antidepressant","volume":"40","author":"D'Agostino","year":"2015","journal-title":"P. T."},{"key":"B63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","article-title":"Abnormal metabotropic glutamatereceptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein\/phospholipase C (PLCbeta1) interactions","volume":"14","author":"Dalf\u00f3","year":"2004","journal-title":"Brain Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00008877-199902000-00006","article-title":"The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function","volume":"10","author":"Dall'Olio","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1523\/JNEUROSCI.23-22-08013.2003","article-title":"Distributionof kainate receptor subunits at hippocampal mossy fiber synapses","volume":"23","author":"Darstein","year":"2003","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/30748","article-title":"Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A","volume":"393","author":"Das","year":"1998","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/cne.902580303","article-title":"The serotoninergic fibers in the dorsal lateral geniculate nucleus of the cat: distribution and synaptic connections demonstrated with immunocytochemistry","volume":"258","author":"De Lima","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.euroneuro.2010.07.001","article-title":"Dopaminergic modulation of the default mode network in Parkinson's disease","volume":"20","author":"Delaveau","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e86624","DOI":"10.1371\/journal.pone.0086624","article-title":"Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study","volume":"9","author":"Delli Pizzi","year":"2014","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0891988716640378","article-title":"Quetiapine for psychosis in parkinson disease and neurodegenerative parkinsonian disorders: a systematic review","volume":"29","author":"Desmarais","year":"2016","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-7091-9211-5_5","article-title":"The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia","author":"Deutch","year":"1992","journal-title":"J. Neural Transm."},{"key":"B75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","article-title":"Repeated visual hallucinations in Parkinson's disease as disturbed external\/internal perceptions: focused review and a new integrative model","volume":"20","author":"Diederich","year":"2005","journal-title":"Mov. Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","article-title":"Hallucinations in Parkinson disease","volume":"5","author":"Diederich","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Res. Bull."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/mp.2012.194","article-title":"Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans","volume":"18","author":"Driesen","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mehy.2013.03.013","article-title":"A serotonin hypothesis of schizophrenia","volume":"80","author":"Eggers","year":"2013","journal-title":"Med. Hypotheses."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1212\/WNL.47.6.1608-b","article-title":"Ondansetron treatment of L-dopa induced psychosis","volume":"47","author":"Eichhorn","year":"1996","journal-title":"Neurology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"103e107","DOI":"10.1016\/S1353-8020(97)00009-6","article-title":"Use of apomorphine in Parkinsonian patients with neuropsychiatric compli- cations to oral treatment, Parkinsonism Relat","volume":"3","author":"Ellis","year":"1997","journal-title":"Disorder"},{"key":"B82","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.amjopharm.2010.08.004","article-title":"Management of hallucinations and psychosis in Parkinson's disease","volume":"8","author":"Eng","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"S7634","DOI":"10.1016\/j.neubiorev.2019.06.006(18)30898-4.","article-title":"Visual hallucinations, thalamocortical physiology and Lewy Body Disease: A Review","volume":"10","author":"Esmaeeli","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B84","first-page":"1","volume-title":"Trait'e des Hallucinations","author":"Ey","year":"1973"},{"key":"B85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"B86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","article-title":"Hallucinations in Parkinson disease in the prelevodopa era","volume":"66","author":"F\u00e9nelon","year":"2006","journal-title":"Neurology"},{"key":"B87","first-page":"S17","article-title":"Psychotic symptoms in Parkinson's disease","volume-title":"Psychol Neuropsychiatr Vieil","author":"F\u00e9nelon","year":"2006"},{"key":"B88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-2999(71)90053-7","article-title":"Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease","volume":"16","author":"Farnebo","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"B89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jrnms-92-64","article-title":"Postoperative vigilance in patients with total intravenous anaesthesia with ketamine\/propofol","volume":"92","author":"Felfernig","year":"2006","journal-title":"J. R. Nav. Med. Serv."},{"key":"B90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacology"},{"key":"B91","doi-asserted-by":"crossref","first-page":"173","DOI":"10.31887\/DCNS.2007.9.2\/dffytche","article-title":"Visual hallucinatory syndromes: past, present, and future","volume":"9","author":"Ffytche","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch. Intern Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1212\/WNL.0000000000006007","article-title":"Reduced occipital GABA in Parkinson disease with visual hallucination","volume":"91","author":"Firbank","year":"2018","journal-title":"Neurology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1176\/ajp.146.7.939b","article-title":"Adverse psychiatric reaction to ketoconazole","volume":"146","author":"Fisch","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0006-8993(87)91296-0","article-title":"Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography","volume":"421","author":"Fischette","year":"1987","journal-title":"Brain Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/syn.890140406","article-title":"Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain","author":"Flynn","year":"1993","journal-title":"Synapse"},{"key":"B97","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1073\/pnas.0504136102","article-title":"The human brain is intrinsically organized into dynamic, anticorrelated functional networks","volume":"102","author":"Fox","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B98","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0140-6736(13)62157-1","article-title":"Pimavanserin as treatment for Parkinson's disease psychosis","volume":"383","author":"Fox","year":"2014","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/mds.26285","article-title":"Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy","volume":"30","author":"Franciotti","year":"2015","journal-title":"Mov. Disord."},{"key":"B100","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00415-009-5247-7","article-title":"Biochemical and pathological correlates of cognitive and behavioural change in DLB\/PDD","volume":"256","author":"Francis","year":"2009","journal-title":"J. Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1073\/pnas.88.9.3772","article-title":"Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission","volume":"88","author":"Fremeau","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B102","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrn2787","article-title":"The free-energy principle: a unified brain theory?","volume":"11","author":"Friston","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1460-9568.2005.03957.x","article-title":"NR2 to NR3B subunit switchover of NMDA receptors in early postnatal motoneurons","volume":"21","author":"Fukaya","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1471-4159.2003.01945.x","article-title":"Assembly and cell surface expression of KA-2 subunit-containing kainate receptors","volume":"86","author":"Gallyas","year":"2003","journal-title":"J. Neurochem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.22063","article-title":"Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study","volume":"23","author":"Garc\u00eda Ruiz","year":"2008","journal-title":"Mov Disord"},{"key":"B106","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1176\/ajp.2007.164.3.450","article-title":"Aberrant \u201cdefault mode\u201d functional connectivity in schizophrenia","volume":"164","author":"Garrity","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0024-3205(88)90315-3","article-title":"Systemic 1-Methyl, 4-Phenyl, 1-2-3-6 tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates","volume":"43","author":"Ghilardi","year":"1988","journal-title":"Life Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1176\/ajp.139.4.494","article-title":"Pharmacology of hallucinations induced by long-term drug therapy","author":"Goetz","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"B110","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archneur.63.5.713","article-title":"The malignant course of \u201cbenign hallucinations\u201d in Parkinson disease","volume":"63","author":"Goetz","year":"2006","journal-title":"Arch. Neurol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/mds.23835","article-title":"Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years","volume":"26","author":"Goetz","year":"2011","journal-title":"Mov. Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/jnc.13398","article-title":"Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors","volume":"136","author":"Goitia","year":"2016","journal-title":"J. Neurochem."},{"key":"B113","first-page":"251","article-title":"Trazodone, nefazodone, bupropion, and mirtazapine","volume-title":"The Amerian Psychiatric Press Textbook of Psychopharmacology,","author":"Golden","year":"1998"},{"key":"B114","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/brain\/awt360","article-title":"Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations","volume":"137","author":"Goldman","year":"2014","journal-title":"Brain"},{"key":"B115","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. In Neurobiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1152\/jn.00361.2010","article-title":"Regulation of inhibitory synapses by presynaptic D\u2084 dopamine receptors in thalamus","volume":"104","author":"Govindaiah","year":"2010","journal-title":"J. Neurophysiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2165\/00044011-200626100-00007","article-title":"Psychotic disorder induced by oxybutynin: Presentation of two cases","volume":"26","author":"Gulsun","year":"2006","journal-title":"Clin. Drug Investig."},{"key":"B121","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF01250276","article-title":"Naloxone-induced reversal of schizophrenic hallucinations","volume":"40","author":"Gunne","year":"1977","journal-title":"J. Neural Transm."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41593-017-0020-1","article-title":"Thalamic functions in distributed cognitive control","volume":"20","author":"Halassa","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B124","first-page":"107","article-title":"Postoperative delirium secondary to atropine premedication","volume":"32","author":"Hammon","year":"1985","journal-title":"Anesth. Prog."},{"key":"B125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-8993(98)00219-4","article-title":"Depletion of dopamine in the prefrontal cortex decreases the basal electrophysiological activity of mesolimbic dopamine neurons","volume":"794","author":"Harden","year":"1998","journal-title":"Brain Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"B127","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5694\/j.1326-5377.1973.tb110479.x","article-title":"Coloured Lilliputian hallucinations with amantadine","volume":"1","author":"Harper","year":"1973","journal-title":"Med. J. Aust."},{"key":"B128","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0165-6147(92)90053-9","article-title":"A subfamily of 5-HT1D receptor genes","volume":"13","author":"Hartig","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/157015905774322516","article-title":"The sigma receptor: evolution of the concept in neuropsychopharmacology","volume":"3","author":"Hayashi","year":"2005","journal-title":"Curr. Neuropharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/1531-8249(200003)47:3<345::AID-ANA10>3.3.CO;2-M","article-title":"Degeneration of the centre median-parafascicular complex in Parkinson's disease","volume":"47","author":"Henderson","year":"2000","journal-title":"Ann. Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1093\/cercor\/bhn017","article-title":"Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex","volume":"18","author":"Henson","year":"2008","journal-title":"Cereb. Cortex"},{"key":"B132","doi-asserted-by":"publisher","first-page":"pyv040","DOI":"10.1093\/ijnp\/pyv040","article-title":"Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia","volume":"18","author":"H\u00f6flich","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review","volume":"97","author":"Hocking","year":"2003","journal-title":"Anesth. Analg."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.mehy.2006.07.061","article-title":"Delusional parasitosis and the dopamine transporter. A new insight of etiology?","volume":"68","author":"Huber","year":"2007","journal-title":"Med. Hypotheses"},{"key":"B135","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/mds.23083","article-title":"Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations","volume":"3025","author":"Huot","year":"2010","journal-title":"Mov. Disord."},{"key":"B137","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1471-4159.2011.07254.x","article-title":"Herms J.AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced \u03b1-synuclein oligomers","volume":"117","author":"H\u00fcls","year":"2011","journal-title":"J. Neurochem."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-008-0114-3","article-title":"Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population","volume":"88","author":"Imataki","year":"2008","journal-title":"Int. J. Hematol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fphar.2018.00330","article-title":"Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process","volume":"9","author":"Inserra","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00002826-199006000-00007","article-title":"Effects of atropine on learning and memory functions in dementia","volume":"13","author":"Inzelberg","year":"1990","journal-title":"Clin. Neuropharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fncir.2018.00051","article-title":"Monoaminergic Neuromodulation of Sensory Processing","volume":"12","author":"Jacob","year":"2018","journal-title":"Front. Neural. Circuits."},{"key":"B142","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00415-011-6149-z","article-title":"The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study","volume":"259","author":"Janzen","year":"2012","journal-title":"J. Neurol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pscychresns.2009.09.005","article-title":"Reduced task-related suppression during semantic repetition priming in schizophrenia","volume":"181","author":"Jeong","year":"2010","journal-title":"Psychiatry Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0163-7258(95)02043-8","article-title":"GABA-A receptor pharmacology","volume":"69","author":"Johnston","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/0896-6273(94)90444-8","article-title":"Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression","volume":"12","author":"Jonas","year":"1994","journal-title":"Neuron"},{"key":"B146","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/abbs\/gmv135","article-title":"The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia","volume":"48","author":"Ju","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B147","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1212\/WNL.44.1.77","article-title":"Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients","volume":"44","author":"Kaakkola","year":"1994","journal-title":"Neurology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2165\/00003495-200059060-00004","article-title":"Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease","volume":"59","author":"Kaakkola","year":"2000","journal-title":"Drugs"},{"key":"B149","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.parkreldis.2004.01.006","article-title":"Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline","volume":"10","author":"Kamakura","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"B150","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine d2receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"B151","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1176\/ajp.124.6.852","article-title":"The use of hyoscyamine as a hallucinogen and intoxicant","volume":"124","author":"Keeler","year":"1967","journal-title":"Am. J. Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.biopsych.2008.12.029","article-title":"Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects","volume":"65","author":"Kessler","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B154","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","article-title":"Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia","volume":"20","author":"Kim","year":"1980","journal-title":"Neurosci. Lett."},{"key":"B155","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/ajp.121.9.911","article-title":"Visual hallucination with imipramine","volume":"121","author":"Klein","year":"1965","journal-title":"Am. Journ. Psy"},{"key":"B156","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/7854_2016_461","article-title":"Serotonergic Hallucinogen-Induced Visual Perceptual Alterations","volume":"36","author":"Kometer","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B157","first-page":"91","article-title":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties","volume":"43","author":"Kornhuber","year":"1994","journal-title":"J. Neural Transm. Suppl."},{"key":"B158","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-6606-5-10","article-title":"M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition","volume":"5","author":"Koshimizu","year":"2012","journal-title":"Mol. Brain."},{"key":"B159","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00702-011-0723-5","article-title":"The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent","volume":"119","author":"Krajcovicova","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B160","first-page":"1","article-title":"The dopamine dysfunction in schizophrenia revisited: new insights into topography and course, Current antipsychotics","volume-title":"Springer","author":"Kuepper","year":"2012"},{"key":"B161","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM198804073181416","article-title":"Disturbing dreams with long-acting verapamil","volume":"318","author":"Kumar","year":"1988","journal-title":"New Engl. J. Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.genhosppsych.2014.02.010","article-title":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","volume":"36","author":"Kuppuswamy","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1021\/acschemneuro.8b00615","article-title":"DARK classics in chemical neuroscience: atropine, scopolamine and other anticholinergic deliriant hallucinogens","volume":"19","author":"Lakstygal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"17461","DOI":"10.1038\/s41598-018-35802-9","article-title":"Glutamatergic and dopaminergic modulation of cortico-striatal circuits probed by dynamic calcium imaging of networks reconstructed in microfluidic chips","volume":"8","author":"Lassus","year":"2018","journal-title":"Sci. Rep."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1176\/ajp.150.11.1750a","article-title":"Dopaminergic hallucinosis with fluoxetine in Parkinson's disease","volume":"150","author":"Lauterbach","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"B166","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/hbm.22833","article-title":"Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin","volume":"36","author":"Lebedev","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"B167","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/brain\/awt162","article-title":"The role of the posterior cingulate cortex in cognition and disease","volume":"137","author":"Leech","year":"2014","journal-title":"Brain"},{"key":"B168","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbamem.2006.11.001","article-title":"Seven transmembrane receptors: a brief personal retrospective","volume":"1768","author":"Lefkowitz","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B169","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrn1118","article-title":"Roles and rules of kainate receptors in synaptic transmission","volume":"4","author":"Lerma","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.1073\/pnas.93.24.13541","article-title":"Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease","volume":"93","author":"Levey","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B171","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Neuroscience"},{"key":"B172","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/WCO.0000000000000381","article-title":"Update on pharmacotherapy for stroke and traumatic brain injury recovery during rehabilitation","volume":"29","author":"Liepert","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archpsyc.1962.01710230020003","article-title":"Subjective Reactions to Lysergic Acid Diethylamide (LSD-25): Measured by a Questionnaire","volume":"6","author":"Linton","year":"1962","journal-title":"Arch. Gen. Psychiatry"},{"key":"B174","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B175","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2147\/NDT.S88156","article-title":"Variation of the default mode network with altered alertness levels induced by propofol","volume":"11","author":"Liu","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B176","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","article-title":"The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study","volume":"17","author":"Liu","year":"2018","journal-title":"Lancet Neurol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"15222","DOI":"10.1073\/pnas.96.26.15222","article-title":"Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography","volume":"96","author":"Llin\u00e0s","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B178","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neubiorev.2015.09.016","article-title":"An integrated network model of psychotic symptoms","volume":"59","author":"Looijestijn","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B179","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2165\/11586440-000000000-00000","article-title":"Effect of memantine on resting state default mode network activity in Alzheimer's disease","volume":"28","author":"Lorenzi","year":"2011","journal-title":"Drugs Aging"},{"key":"B180","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0269881117699614","article-title":"Low-dose systemic scopolamine disrupts context conditioning in rats","volume":"31","author":"Luyten","year":"2017","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"B181","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0022-5347(17)43295-2","article-title":"Comparison of calcium antagonist properties of antispasmotic agents","volume":"138","author":"Malkowicz","year":"1987","journal-title":"J. Urol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/121.10.1819","article-title":"Complex visual hallucinations. Clinical and neurobiological insights","volume":"121","author":"Manford","year":"1998","journal-title":"Brain"},{"key":"B183","doi-asserted-by":"publisher","first-page":"pii: pyv065","DOI":"10.1093\/ijnp\/pyv065","article-title":"Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans","volume":"18","author":"Maqueda","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2515\/therapie:2008036","article-title":"Propofol-induced hallucinations and dreams","volume":"63","author":"Marchaisseau","year":"2008","journal-title":"Therapie"},{"key":"B185","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0306-4522(01)00199-3","article-title":"A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex","volume":"105","author":"Marek","year":"2001","journal-title":"Neuroscience"},{"key":"B186","first-page":"90","article-title":"Erotic hallucinations associated with the use of propofol","volume":"47","author":"Mart\u00ednez Villar","year":"2000","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"key":"B187","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-2999(83)90518-6","article-title":"Specific inhibitory action of certain benzothiazepines and benzodiazepines on the sodium-calcium exchange process of heart and brain mitochondria","volume":"89","author":"Matlib","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1016\/j.lfs.2004.05.034","article-title":"Functional analysis of muscarinic acetylcholine receptors using knockout mice","volume":"75","author":"Matsui","year":"2004","journal-title":"Life Sci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/319402a0","article-title":"Acetylcholine induces burst firing in thalamic reticular neurones by activating a potassium conductance","volume":"319","author":"McCormick","year":"1986","journal-title":"Nature"},{"key":"B190","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1113\/jphysiol.1991.sp018791","article-title":"Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami","volume":"442","author":"McCormick","year":"1991","journal-title":"J. Physiol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"B192","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"International Psychogeriatric Association expert meeting on DLB, dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B194","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and \u03b2-carboline constituents of Ayahuasca","volume":"10","author":"McKenna","year":"1984","journal-title":"J. Ethnopharmacology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/npp.2009.176","article-title":"Pimavanserin, a Serotonin 2A Receptor inverse agonist, for the treatment of Parkinson's disease Psychosis","volume":"35","author":"Meltzer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B196","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3233\/JAD-2005-8307","article-title":"Exacerbation of Lewy bodies dementia due to memantine","volume":"8","author":"Menendez-Gonzalez","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"key":"B199","doi-asserted-by":"publisher","first-page":"791e804","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic recep- tor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B200","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4682-7-10","article-title":"A thalamic reticular networking model of consciousness","volume":"7","author":"Min","year":"2010","journal-title":"Theor. Biol. Med. Model"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1179069518779829","DOI":"10.1177\/1179069518779829","article-title":"Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease","volume":"12","author":"Mishra","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"B203","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"B204","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/00019442-200307000-00014","article-title":"Musical hallucinations induced by oxycodone","volume":"11","author":"Moore","year":"2003","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B205","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<385::AID-CNE7>3.0.CO;2-Q","article-title":"Distribution of Neurons Expressing Immunoreactivity for the 5-HT3 Receptor Subtype in the Rat Brain and Spinal Cord","volume":"385","author":"Morales","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/7854_2016_29","article-title":"The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs","volume":"39","author":"Mori","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cne.902430110","article-title":"Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys","volume":"243","author":"Morrison","year":"1986","journal-title":"J. Comp. Neurol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1176\/ajp.135.6.669","article-title":"Levodopa-induced psychosis: a kindling phenomenon","volume":"135","author":"Moskovitz","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"B209","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0404.1997.tb00101.x","article-title":"Selegiline as the primary treatment of Parkinson's disease-a long-term double-blind study","volume":"95","author":"Myllyl\u00e4","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1017\/S1041610212002037","article-title":"A case in which myrtazapine reduced auditory hallucinations in a patient with Parkinson disease","volume":"25","author":"Nagata","year":"2013","journal-title":"Int. Psychogeriatrics"},{"key":"B212","doi-asserted-by":"publisher","first-page":"e10382","DOI":"10.7554\/eLife.10382","article-title":"Selectively driving cholinergic fibers optically in the thalamic reticular nucleus promotes sleep","volume":"5","author":"Ni","year":"2016","journal-title":"Elife"},{"key":"B213","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B214","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/ALN.0b013e31826a0db3","article-title":"Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers","volume":"117","author":"Niesters","year":"2012","journal-title":"Anesthesiology"},{"key":"B216","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: Physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2005.04.002","article-title":"Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies","volume":"139","author":"O'Brien","year":"2005","journal-title":"Psychiatry Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuroimage.2008.01.010","article-title":"Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations","volume":"40","author":"O'Brien","year":"2008","journal-title":"Neuroimage"},{"key":"B219","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0278-5846(98)00006-2","article-title":"Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease","volume":"22","author":"Ohara","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B220","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1460-9568.2003.02732.x","article-title":"Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus","volume":"18","author":"Ohno-Shosaku","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11920-016-0730-1","article-title":"Current understanding of psychosis in Parkinson's disease","volume":"18","author":"Ojo","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"B222","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/0006-3223(95)00195-M","article-title":"Fluoxetine and visual hallucinations in dementia","volume":"38","author":"Omar","year":"1995","journal-title":"Biol. Psych."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/mds.10217","article-title":"Olanzapine treatment for dopaminergic-induced hallucinations","volume":"17","author":"Ondo","year":"2002","journal-title":"Mov. Disord."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/jnnp.49.10.1150","article-title":"Visual evoked potentials in Parkinsonism and dopamine blockade reveal a stimulus- dependent dopamine function in humans","volume":"49","author":"Onofrj","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B225","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000050749","article-title":"Switch-over from tolcapone to entacapone in severe Parkinson's disease patients","volume":"46","author":"Onofrj","year":"2001","journal-title":"Eur. Neurol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1007\/s100720200085","article-title":"Visual hallucinations in PD and lewy body dementias: Old and new hypotheses 491 patients affected by Parkinson's disease: 8-year follow-up","volume":"23","author":"Onofrj","year":"2002","journal-title":"Neurological Sci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00002826-200309000-00008","article-title":"The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia","volume":"26","author":"Onofrj","year":"2003","journal-title":"ClinNeuropharmacology"},{"key":"B228","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2006.05.025","article-title":"Visual hallucinations in Parkinson's disease: clues to separate origins","volume":"248","author":"Onofrj","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1586\/14737175.7.12.1731","article-title":"New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins","volume":"7","author":"Onofrj","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"B230","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3233\/BEN-129022.","article-title":"Visual hallucinations in PD and Lewy body dementias: old and new hypotheses","volume":"27","author":"Onofrj","year":"2013","journal-title":"Behav. Neurol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/mds.27781","article-title":"Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction","volume":"34","author":"Onofrj","year":"2019","journal-title":"Mov. Disord."},{"key":"B232","doi-asserted-by":"publisher","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PloS One"},{"key":"B233","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11920-018-0869-z","article-title":"Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis","volume":"20","author":"Panchal","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/AAC.02739-15","article-title":"Visual hallucinations associated with high posaconazole concentrations in serum","volume":"60","author":"Parkes","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B235","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archneur.62.2.241","article-title":"A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study","volume":"62","year":"2005","journal-title":"Arch. Neurol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"B238","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","article-title":"Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors","volume":"346","author":"Pazos","year":"1985","journal-title":"Brain Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00228-013-1517-5","article-title":"Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol","volume":"69","author":"Pellegrino","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1471-4159.1990.tb03162.x","article-title":"Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia","volume":"55","author":"Perry","year":"1990","journal-title":"J. Neurochem."},{"key":"B241","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","article-title":"Cholinergic and dopaminergic activities in senile dementia of Lewy body type","volume":"4","author":"Perry","year":"1990","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B242","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00002093-199307020-00002","article-title":"Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease","volume":"7","author":"Perry","year":"1993","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B243","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02260919","article-title":"Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features","volume":"6","author":"Perry","year":"1993","journal-title":"J. Neural Transm. Park Dis. Dement. Sect."},{"key":"B244","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","article-title":"Acetylcholine in mind: a neurotransmitter correlate of consciousness","volume":"22","author":"Perry","year":"1999","journal-title":"Trends In Neurosci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S146114570600647X","article-title":"Thalamic D2 receptors in dementia with lewy bodies, Parkinson's disease, and Parkinson's disease dementia","volume":"10","author":"Piggott","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nbd.2005.06.008","article-title":"Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies","volume":"21","author":"Pimlott","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.04.008","article-title":"The thalamic reticular nucleus: structure, function and concept","volume":"46","author":"Pinault","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B248","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nm.2315","article-title":"Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors","volume":"17","author":"Pitcher","year":"2011","journal-title":"Nat. Med."},{"key":"B249","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/mds.20700","article-title":"Long-term benefits of rivastigmine in dementia associ- ated with Parkinson's disease: an active treatment extension study","volume":"21","author":"Poewe","year":"2006","journal-title":"Mov. Disord."},{"key":"B250","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/mds.10567","article-title":"Psychosis in Parkinson's disease","volume":"18","author":"Poewe","year":"2003","journal-title":"Mov. Disord."},{"key":"B251","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson's disease","volume":"277","author":"Politis","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B252","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B253","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1532-5415.1975.tb00187.x","article-title":"Visual hallucinations and delirium during treatment with amantadine (Symmetrel)","volume":"23","author":"Postma","year":"1975","journal-title":"J. Am. Geriatr. Soc"},{"key":"B254","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B255","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X","article-title":"Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization","volume":"425","author":"Quik","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.21116","article-title":"Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration","volume":"22","author":"Rabey","year":"2007","journal-title":"Mov. Disord."},{"key":"B257","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":"A default mode of brain function","volume":"98","author":"Raichle","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B258","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","article-title":"The brain's default mode network","volume":"38","author":"Raichle","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"B259","first-page":"58","article-title":"Psychosis following Tramadol Withdrawal","volume":"1","author":"Rajabizadeh","year":"2009","journal-title":"Addict. Health"},{"key":"B260","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.20965","article-title":"Neuropsychological deficits in Parkinson's disease patients with visual hallucinations","volume":"21","author":"Ram\u00edrez-Ruiz","year":"2006","journal-title":"Mov. Disord."},{"key":"B261","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000100850","article-title":"Cognitive changes in Parkinson's disease patients with visual hallucinations","volume":"23","author":"Ramirez-Ruiz","year":"2007","journal-title":"Dement Geriatr. Cognit. Disord."},{"key":"B262","doi-asserted-by":"publisher","first-page":"349","DOI":"10.14336\/AD.2015.0330","article-title":"Dopamine Receptors and Neurodegeneration","volume":"6","author":"Rangel-Barajas","year":"2015","journal-title":"Aging Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"B264","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1017\/neu.2013.61","article-title":"Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control","volume":"26","author":"Rasmussen","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"B265","doi-asserted-by":"publisher","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PloS One"},{"key":"B266","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology"},{"key":"B267","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00213-006-0358-7","article-title":"Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant","volume":"186","author":"Riba","year":"2006","journal-title":"Psychopharmacol. (Berl.)"},{"key":"B268","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"Ridha","year":"2005","journal-title":"Neurology"},{"key":"B269","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/sj.npp.1300336","article-title":"Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies","volume":"29","author":"Rieck","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B270","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/0140-6736(91)91888-2","article-title":"Pharmacotoxic psychosis after memantine in Parkinson's disease","volume":"338","author":"Riederer","year":"1991","journal-title":"Lancet"},{"key":"B271","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/syn.20920","article-title":"Serotonergic projections and serotonin receptor expression in the reticular nucleus of the thalamus in the rat","volume":"65","author":"Rodr\u00edguez","year":"2011","journal-title":"Synapse"},{"key":"B272","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnsys.2014.00019","article-title":"Cortico-cortical communication dynamics","volume":"8","author":"Roland","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"B273","doi-asserted-by":"publisher","first-page":"307106","DOI":"10.1155\/2014\/307106","article-title":"Pharmacology of hallucinations: several mechanisms for one single symptom","volume":"2014","author":"Rolland","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"B274","doi-asserted-by":"publisher","first-page":"9687","DOI":"10.1523\/JNEUROSCI.22-22-09687.2002","article-title":"NMDA receptor 2 (NR2) C-terminal control of NR open probability regulates synaptic transmission and plasticity at a cerebellar synapse","volume":"22","author":"Rossi","year":"2002","journal-title":"J. Neurosci."},{"key":"B275","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B276","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","article-title":"Excitotoxicity and the NMDA receptor","volume":"10","author":"Rothman","year":"1987","journal-title":"Trends Neurosci."},{"key":"B277","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(01)00269-X","article-title":"Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology","volume":"23","author":"Rub","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"B278","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0968-05.2005","article-title":"The primate thalamus is a key target for brain dopamine","volume":"25","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2005","journal-title":"J Neurosci"},{"key":"B279","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin. Ther."},{"key":"B280","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N","article-title":"Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex","volume":"390","author":"Scherzer","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"B282","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","article-title":"The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies","volume":"25","author":"Seidel","year":"2015","journal-title":"Brain Pathol."},{"key":"B283","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD008191.pub2","article-title":"Antidepressants for agitation and psychosis in dementia","volume":"2","author":"Seitz","year":"2011","journal-title":"Coch. Collab."},{"key":"B284","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejphar.2015.05.012","article-title":"Opioid receptors: Structural and mechanistic insights into pharmacology and signaling","volume":"763","author":"Shang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B285","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nn.4269","article-title":"Thalamus plays a central role in ongoing cortical functioning","volume":"19","author":"Sherman","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B286","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12149-017-1166-3","article-title":"Correlation between clinical symptoms and striatal DAT uptake in patients with DLB","volume":"31","author":"Shimizu","year":"2017","journal-title":"Ann. Nuclear Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pneurobio.2014.01.004","article-title":"Tricks of the mind: visual hallucinations as disorders of attention","volume":"116","author":"Shine","year":"2014","journal-title":"Prog. In Neurobiol."},{"key":"B288","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/npjparkd.2015.3","article-title":"Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: a task-based fMRI study","volume":"1","author":"Shine","year":"2015","journal-title":"NPJ Parkinsons Dis."},{"key":"B289","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"B290","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fncir.2014.00052","article-title":"mRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brain","volume":"8","author":"Shukla","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1001\/archneur.59.12.1937","article-title":"A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study","volume":"59","author":"Siderowf","year":"2002","journal-title":"Arch. Neurol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0197-0186(99)00045-5","article-title":"Structure and subunit composition of GABAA receptors","volume":"34","author":"Sieghart","year":"1999","journal-title":"Neurochemistry Int."},{"key":"B293","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/mds.26327","article-title":"Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies","volume":"31","author":"Siepel","year":"2016","journal-title":"Mov. Disord."},{"key":"B294","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1213\/ANE.0000000000001417","article-title":"Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment","volume":"123","author":"Sivanesan","year":"2016","journal-title":"Anesth. Analg."},{"key":"B295","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2045125317718810","article-title":"Acetylcholinesterase inhibitors in treatment-resistant psychotic depression","volume":"8","author":"Smart","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0165-6147(00)89009-4","article-title":"Functional domains of GABA-A receptors, Trends Pharmacol","volume":"16","author":"Smith","year":"1995","journal-title":"Science"},{"key":"B297","doi-asserted-by":"publisher","first-page":"171e176","DOI":"10.1007\/BF01250567","article-title":"Effect of apomorphine on schizophrenic symptoms","volume":"40","author":"Smith","year":"1977","journal-title":"J. Neural Transm."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1176\/appi.ajp.2008.08081228","article-title":"Amantadine-induced psychosis in a young healthy patient","volume":"165","author":"Smith","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"B299","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0091-3057(95)02130-2","article-title":"Muscarinic antagonists are anxiogenic in rats tested in the black-white box","volume":"54","author":"Smythe","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B300","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/yco.0000000000000416","article-title":"Toward personalized treatment of hallucinations","volume":"31","author":"Sommer","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"B301","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2221-1691(13)60014-3","article-title":"Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview","volume":"2","author":"Soni","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"B302","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neubiorev.2007.02.005","article-title":"Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis","volume":"31","author":"Sonuga-Barke","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B303","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1092852915000139","article-title":"Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors)","volume":"20","author":"Stahl","year":"2015","journal-title":"CNS Spectrums"},{"key":"B304","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid Receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"B305","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.biopsych.2018.05.015","article-title":"The Predictive Coding Account of Psychosis","volume":"84","author":"Sterzer","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B306","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/schbul\/sbn009","article-title":"Cortical dopamine D2\/D3 receptors are a common site of action for antipsychotic drugs\u2013an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature","volume":"35","author":"Stone","year":"2009","journal-title":"Schizophr. Bull."},{"key":"B307","doi-asserted-by":"publisher","first-page":"2e7","DOI":"10.1016\/j.genhosppsych.2013.10.016","article-title":"Trimethoprim-sulfamethoxazole-related hallucinations","volume":"36","author":"Stuhec","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"B308","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1523\/JNEUROSCI.3177-12.2013","article-title":"Biphasic cholinergic synaptic transmission controls action potential activity in thalamic reticular nucleus neurons","volume":"33","author":"Sun","year":"2013","journal-title":"J. Neurosci."},{"key":"B309","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejps.2015.03.020","article-title":"A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain","volume":"74","author":"Sverrisd\u00f3ttir","year":"2015","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"B310","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrd1630","article-title":"Metabotropic glutamate receptors as novel targets for anxiety and stress disorders","volume":"4","author":"Swanson","year":"2005","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B311","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1479-8301.2012.00432.x","article-title":"Mirtazapine improbe visual hallucinations in Parkinson's disease: a case report","volume":"13","author":"Tagai","year":"2013","journal-title":"Psychogeriatrics"},{"key":"B312","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0278-5846(03)00040-X","article-title":"Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series","volume":"27","author":"Takahashi","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B313","doi-asserted-by":"publisher","first-page":"567e568","DOI":"10.1126\/science.347574","article-title":"Schizophrenic symptoms improve with apomorphine","volume":"200","author":"Tamminga","year":"1978","journal-title":"Science"},{"key":"B314","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1213\/ANE.0000000000001594","article-title":"Opioid-Induced Hallucination: Distressful or Sought After","volume":"123","author":"Tan","year":"2016","journal-title":"Anesth. Analg."},{"key":"B315","doi-asserted-by":"publisher","first-page":"e6102","DOI":"10.1371\/journal.pone.0006102","article-title":"Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention","volume":"4","author":"Tomasi","year":"2009","journal-title":"PloS One"},{"key":"B316","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function [published correction appears in Pharmacol Rev. 2014 Oct;66(4):1141]","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B317","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrn.2015.21","article-title":"Mechanisms and functions of GABA co-release","volume":"17","author":"Tritsch","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B318","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000017164","article-title":"Update on the neuropathogenesis of delirium","volume":"10","author":"Trzepacz","year":"1999","journal-title":"Dement Geriatr. Cognit. Disord."},{"key":"B319","doi-asserted-by":"publisher","first-page":"132","DOI":"10.153\/scnp00500132","article-title":"Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine","volume":"5","author":"Trzepacz","year":"2000","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"B320","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1874473708666150107120930","article-title":"A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment","volume":"7","author":"Turton","year":"2014","journal-title":"Curr. Drug Abuse Rev."},{"key":"B321","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(01)00212-2","article-title":"Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials","volume":"56","author":"Tuunainen","year":"2002","journal-title":"Schizophr. Res."},{"key":"B322","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/brain\/aws126","article-title":"Pareidolias: complex visual illusions in dementia with Lewy bodies","volume":"135","author":"Uchiyama","year":"2012","journal-title":"Brain"},{"key":"B323","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B324","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1192\/bjp.159.6.888","article-title":"Musical hallucinations triggered by clomipramine?","volume":"159","author":"Vallada","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"B325","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41467-018-02820-0","article-title":"Thalamocortical dysrhythmia detected by machine learning","volume":"9","author":"Vanneste","year":"2018","journal-title":"Nat. Commun."},{"key":"B326","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1152\/jn.00578.2007","article-title":"Differences in Response to Muscarinic Activation Between First and Higher Order Thalamic Relays","volume":"98","author":"Varela","year":"2007","journal-title":"J. Neurophysiology"},{"key":"B327","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fncir.2014.00069","article-title":"Thalamic neuromodulation and its implications for executive networks","volume":"8","author":"Varela","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"B328","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4140\/TCP.n.2016.207","article-title":"Ertapenem-induced hallucinations and delirium in an elderly patient","volume":"31","author":"Veillette","year":"2016","journal-title":"Consultant Pharmacist\u00ae"},{"key":"B329","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/(SICI)1096-9861(19990517)407:4<555::AID-CNE7>3.0.CO;2-E","article-title":"Projections of the median raphe nucleus in the rat","volume":"407","author":"Vertes","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"B330","doi-asserted-by":"crossref","first-page":"265","DOI":"10.31887\/DCNS.2001.3.4\/fxvollenweider","article-title":"Brain mechanisms of hallucinogens and entactogens","volume":"3","author":"Vollenweider","year":"2001","journal-title":"Dialogues Clin. Neurosci."},{"key":"B331","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"key":"B332","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/252588a0","article-title":"LSD as an agonist and antagonist at central dopamine receptors","volume":"252","author":"von Hungen","year":"1974","journal-title":"Nature"},{"key":"B333","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid Receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"B334","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/mds.23964","article-title":"Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine","author":"Walsh","year":"2012","journal-title":"Mov. Disord."},{"key":"B335","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/aps.2010.138","article-title":"The role of kappa-opioid receptor activation in mediating antinociception and addiction","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"B336","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.concog.2011.01.007","article-title":"The thalamic dynamic core theory of conscious experience","volume":"20","author":"Ward","year":"2011","journal-title":"Conscious Cogn."},{"key":"B337","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/wcs.1256","article-title":"The thalamus: gateway to the mind","volume":"4","author":"Ward","year":"2013","journal-title":"Wiley Interdiscip. Rev. Cognit. Sci."},{"key":"B338","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"B339","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaneurol.2016.0031","article-title":"Association of antipsychotic use with mortality risk in patients with Parkinson disease","volume":"73","author":"Weintraub","year":"2016","journal-title":"JAMA Neurol."},{"key":"B340","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0166-2236(00)01610-6","article-title":"Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration","volume":"23","author":"Weiss","year":"2000","journal-title":"Trends Neurosci."},{"key":"B341","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0165-6147(00)01541-8","article-title":"Zn(2+): a novel ionic mediator of neural injury in brain disease","volume":"21","author":"Weiss","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"B342","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn1727","article-title":"The neural bases of momentary lapses in attention","volume":"9","author":"Weissman","year":"2006","journal-title":"Nat. Neurosci."},{"key":"B343","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0024-3205(97)00041-6","article-title":"Structural basis of receptor\/G protein coupling selectivity studied with muscarinic receptors as model systems","volume":"60","author":"Wess","year":"1997","journal-title":"Life Sci."},{"key":"B344","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2165\/00003495-199652050-00010","article-title":"Ondansetron: A Review of its Pharmacology and Preliminary Clinical Findings in Novel Application","volume":"52","author":"Wilde","year":"1996","journal-title":"Drugs"},{"key":"B345","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(19)30140-1","article-title":"Serotonergic pathology and disease burden in the premotor and motor phase of A53T \u03b1-synuclein parkinsonism: a cross-sectional study","volume":"18","author":"Wilson","year":"2019","journal-title":"Lancet Neurol."},{"key":"B347","doi-asserted-by":"publisher","first-page":"e12818","DOI":"10.1371\/journal.pone.0012818","article-title":"A role for calcium-permeable AMPA receptors in synaptic plasticity and learning","volume":"5","author":"Wiltgen","year":"2010","journal-title":"PloS One"},{"key":"B348","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00412109","article-title":"Comparison of psilocin with psilocybin, mescaline and LSD-25","volume":"3","author":"Wolbach","year":"1962","journal-title":"Psychopharmacologia"},{"key":"B349","first-page":"S13","article-title":"Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment","volume":"52","author":"Wolters","year":"1999","journal-title":"Neurology"},{"key":"B350","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/schbul\/sbt161","article-title":"Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis","volume":"40","author":"Wotruba","year":"2014","journal-title":"Schizophr. Bull."},{"key":"B351","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnmol.2012.00034","article-title":"The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain","volume":"5","author":"Wright","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"B352","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2013.03.023","article-title":"Dopaminergic modulation of tonic but not phasic GABAA-receptor-mediated current in the ventrobasal thalamus of Wistar and GAERS rats","volume":"247","author":"Yag\u00fce","year":"2013","journal-title":"Exp. Neurol."},{"key":"B353","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"B354","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1440-1819.2011.02211.x","article-title":"Hallucinations induced by paroxetine discontinuation in patients with major depressive disorders","volume":"65","author":"Yasui-Furukori","year":"2011","journal-title":"Psy. Clin. Neurosci."},{"key":"B355","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice","author":"Zhang","year":"2002","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"B356","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jemermed.2017.05.003","article-title":"Postoperative Anticholinergic Poisoning: Concealed Complications of a Commonly Used Medication","author":"Zhang","year":"2017","journal-title":"J. Emerg. Med."},{"key":"B357","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2967\/jnumed.112.114025","article-title":"Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies","volume":"54","author":"Ziebell","year":"2013","journal-title":"J. Nuclear Med."},{"key":"B358","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/0140-6736(93)90327-D","article-title":"Ondansetron for hallucinosis in advanced Parkinson's disease","volume":"341","author":"Zoldan","year":"1993","journal-title":"Lancet"},{"key":"B359","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson's disease: treatment with Ondansetron, a 5-HT3 receptor antagonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01379\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:52:57Z","timestamp":1665190377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01379\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":359,"alternative-id":["10.3389\/fphar.2019.01379"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01379","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"article-number":"1379"}}